Schedule 13G ownership disclosure
NABRIVA THERAPEUTICS PLC
Security class unavailable · CUSIP: G63637105
Event date: 2019-08-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,528,566
- Percent of class
- 4.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001615774-19-011241
- Form type
- SC 13G
- Filer
- Nabriva Therapeutics plc
- CIK
- CIK 1641640
- Filed
- Aug 14, 2019
- Reporting period
- Aug 13, 2019
- Description
- Schedule 13G beneficial ownership